Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) EBITDA: 2024-2025

Historic EBITDA for NewGenIvf (NIVF) over the last 2 years, with Sep 2025 value amounting to -$249.7 billion.

  • NewGenIvf's EBITDA fell 87098784.72% to -$249.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$230.8 billion, marking a year-over-year change of. This contributed to the annual value of -$441,572 for FY2024, which is 615.17% down from last year.
  • Per NewGenIvf's latest filing, its EBITDA stood at -$249.7 billion for Q3 2025, which was down 622,830,896.70% from -$40,093 recorded in Q2 2025.
  • Over the past 5 years, NewGenIvf's EBITDA peaked at $18.9 billion during Q4 2024, and registered a low of -$249.7 billion during Q3 2025.